Virbac (Australia) Pty Ltd.
Records under this name other than patents Virbac (Australia) Pty Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Virbac (Australia) Pty Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,052,982 | Bioimplant formulation comprising lecithin and stearin Term ended Term ended Dec 31, 2022 · USPTO record | Term ended | Term ended Dec 31, 2022 | USPTO record |
| US 6,913,761 | Bioimplant formulation Term ended Term ended Jul 20, 2019 · USPTO record | Term ended | Term ended Jul 20, 2019 | USPTO record |
| US 6,777,386 | Sustained peptide-release formulation Term ended Term ended Mar 5, 2019 · USPTO record | Term ended | Term ended Mar 5, 2019 | USPTO record |
| US 6,337,318 | Sustained GnRH peptide-release formulation Term ended Term ended Feb 19, 2019 · USPTO record | Term ended | Term ended Feb 19, 2019 | USPTO record |
| US 6,211,152 | Formulations for peptide release Term ended Term ended Feb 17, 2019 · USPTO record | Term ended | Term ended Feb 17, 2019 | USPTO record |
| US 7,309,689 | Sustained peptide-release formulation Term ended Term ended May 27, 2018 · USPTO record | Term ended | Term ended May 27, 2018 | USPTO record |
| US 5,925,619 | Formulation for peptide release Term ended Term ended no later than Jul 20, 2019 · Low confidence | Term ended | Term ended no later than Jul 20, 2019 | Low confidence |